Xenografting of Breast Cancer Cells using VitroGel System

RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers.

In this research highlight, a joint team of researchers from Korean and Japanese cancer institutes performed a series of in vitro and in vivo experiments to investigate the expression and mode of action of the ring-finger protein RFN208. VitroGel, a xeno-free injectable hydrogel system was used for xenografting of triple-negative breast cancer cells into mice to help cell retention and test tumor growth in response to the upregulation of a ubiquitin-related ligase protein. The results show that RNF208 expression is closely associated with Vimentin-mediated aggressive cancer progression of breast cancer cells.

 

Click here for the full research highlights.

 

Read how VitroGel helps with this research.

 

Do you know that xeno-free VitroGel hydrogels can be used as a Matrigel alternative for 3D cell culture research? Click here to find out more.